Company Profile
Lunac Therapeutics Limited
11317849•Private Limited With Share Capital
Get Full Access
18/04/2018
8 years
4
1
72190
not scored
Company Overview
Registration, classification & business activity
Lunac Therapeutics Limited (11317849) is a private limited with share capital incorporated on 18/04/2018 (8 years old) and registered in london, WC2N5NT. The company operates under SIC code 72190 - other research and experimental development on natural sciences and engineering.
Lunac therapeutics is a spin out from the university of leeds, uk and is pursuing the discovery of next generation oral anticoagulant therapies with a reduced risk of causing bleeding compared to current treatments. the business is founded on ip generated by professor helen philippou (professor of t...
Financial Overview
£843.8K
£4.77M
£-3.93M
£775.0K
Key Metrics
1
Employees
4
Directors
14
Shareholders
1
Patents
Board of Directors
Innovate Grants
This company received a grant of £1610864.5 for Development Of First-In Class Small Molecule Preclinical Candidate Anticoagulant Targeting Activated Factor Xii With Minimal Risk Of Bleeding. The project started on 01/09/2019 and ended on 31/05/2021.
This company received a grant of £249917.0 for Continuity Award Of Development Of First-In Class Small Molecule Preclinical Candidate Anticoagulant Targeting Activated Factor Xii With Minimal Risk Of Bleeding -105439. The project started on 01/06/2020 and ended on 30/11/2020.
Import / Export
Risk Assessment
not scored
International Score
Future Factor
fair
Performance Rating